No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
110 |
4. Check minimum number of eventsNone |
110 |
5. Include endpointsNone |
110 |
6. Filter based on genotype QC (FinnGen only) |
103 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Similar endpoints
↥List of similar endpoints to
Idiopathic hypoparathyroidism
based on the number of shared cases.
Similar with more cases:
- Hypoparathyroidism
- Disorders of parathyroid gland
- Disorders of other endocrine glands
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 103 | 73 | 30 |
| Unadjusted period prevalence (%) | 0.02 | 0.03 | 0.01 |
| Median age at first event (years) | 54.33 | 53.21 | 57.03 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 110
- Matched controls
- 1100
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E20.0
ICD-10 Finland
Idiopathic hypoparathyroidism
+∞
158.7
110
*
A11CC03
ATC
alfacalcidol; systemic
155.5
51.3
51
6
106
Kela drug reimbursment
Hypoparathyroidism
+∞
51.1
45
*
A12AA04
ATC
calcium carbonate; oral
160.8
41.1
41
*
A11CC02
ATC
dihydrotachysterol; oral
388.9
30.4
29
*
E20.9
ICD-10 Finland
Hypoparathyroidism, unspecified
+∞
28.4
26
*
E83.51
ICD-10 Finland
Hypocalcemia
176.8
27.0
27
*
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
64.8
25.8
29
6
A12AA06
ATC
calcium lactate gluconate; oral
+∞
19.3
18
*
E20.8
ICD-10 Finland
Other hypoparathyroidism
+∞
16.0
15
*
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
185.3
15.9
16
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.8
11.0
66
309
104
Kela drug reimbursment
Thyroid insufficiency
5.5
10.9
24
53
KA1AE
NOMESCO Finland
Kidney ultrasound examination
17.6
9.3
14
9
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
22.2
8.7
12
6
E21.0
ICD-10 Finland
Primary hyperparathyroidism
14.4
8.6
14
11
E20
ICD-10 Finland
Hypoparathyroidism
+∞
8.4
8
*
E83.50
ICD-10 Finland
Hypercalcemia
17.3
7.4
11
7
H03AA01
ATC
levothyroxine sodium; systemic
3.1
7.0
42
185
BBA30
NOMESCO Finland
Excision of lesion of parathyroid gland
24.3
6.8
9
*
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
24.3
6.8
9
*
Z3231
NOMESCO Finland
Registered nurse
2.7
6.1
46
228
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
51
73
12.16
37.54
4.5
4.0
56.74
79.84
ng/l
0.82
38
61
86
455
5.08
12.56
22.4
6.8
1.15
1.22
mmol/l
5.45
75
382
59
314
2.90
7.00
8.2
3.4
2.23
2.36
mmol/l
3.73
54
276
14
48
3.20
3.44
2.1
2.8
1.42
1.45
g/l
0.07
14
42
6
8
7.85
3.09
1.7
4.9
—
—
—
0
0
104
919
3.41
2.89
31.5
16.5
140.27
139.70
mmol/l
1.57
104
891
104
920
3.39
2.89
31.7
16.6
3.88
3.97
mmol/l
2.32
104
893
51
341
1.92
2.83
3.8
3.3
—
—
—
0
0
5
6
8.65
2.77
2.0
3.5
—
—
—
0
0
71
545
1.85
2.43
8.2
10.1
4.60
4.14
e9/l
1.02
66
470
41
266
1.86
2.42
5.1
3.6
4.79
8.54
mg/mmol
0.72
29
155
5
8
6.48
2.39
1.6
2.1
—
—
—
0
0
5
8
6.48
2.39
11.8
2.1
15.94
5.09
nmol/l
—
5
8
51
356
1.81
2.37
4.8
4.2
—
—
—
0
0
104
942
2.91
2.10
33.1
16.6
85.21
76.08
umol/l
1.74
104
942
5
10
5.18
2.09
1.4
1.1
206.40
308.90
pmol/l
—
5
10
9
32
2.97
2.05
1.0
2.3
—
—
—
0
0
61
462
1.72
2.05
4.6
4.0
0.00
0.00
estimate
-0.00
16
100
61
464
1.71
2.00
6.7
5.5
0.00
0.00
estimate
-0.00
13
93
40
271
1.75
1.99
3.3
3.1
0.24
0.32
e6/l
0.32
34
197
24
139
1.93
1.96
4.7
2.4
12.45
13.00
umol/l
0.14
24
127
23
133
1.92
1.88
4.5
2.3
2.38
2.33
g/l
0.17
23
122
61
471
1.66
1.84
4.6
4.0
0.00
0.00
estimate
-0.00
15
88
55
414
1.66
1.83
22.4
13.8
1.29
1.28
inr
0.02
19
122
11
48
2.44
1.77
2.7
3.9
0.03
0.11
e6/l
1.09
11
48
7
24
3.04
1.75
3.1
3.0
24.56
24.88
mmol/l
—
7
24
5
13
3.97
1.73
1.6
1.8
—
—
—
0
0
6
21
2.96
1.53
3.5
2.1
35.67
75.80
ug/min
—
6
13
12
59
2.16
1.50
19.4
3.1
141.92
226.96
ng/l
0.63
12
53
10
46
2.29
1.45
9.6
4.6
35.27
43.60
%
—
10
46
24
153
1.73
1.44
1.4
1.3
26.50
27.09
iu/ml
—
6
51
35
247
1.61
1.44
4.7
4.2
0.00
0.00
estimate
-0.00
16
94
18
108
1.80
1.32
2.0
1.7
—
—
—
0
0
18
108
1.80
1.32
2.0
1.8
—
—
—
0
0
6
24
2.58
1.32
1.2
1.3
—
3.80
—
0
5
12
63
2.02
1.28
1.7
1.6
—
—
—
0
0
13
71
1.94
1.25
3.3
2.8
5.22
4.24
ug/l
0.16
13
64
94
847
1.75
1.25
21.4
13.7
74.75
80.17
ml/min/173m2
0.99
82
679
24
160
1.64
1.23
2.2
2.9
1.78
0.96
e6/l
0.34
16
86
5
19
2.71
1.23
1.6
1.7
—
—
—
0
0
22
145
1.65
1.17
2.1
1.8
—
—
—
0
0
5
21
2.44
1.10
1.2
1.2
—
—
—
0
0
46
365
1.45
1.07
2.1
1.9
84.81
97.65
pmol/l
0.95
25
168
5
22
2.33
1.04
1.8
3.5
63.40
63.95
%
—
5
22
44
348
1.44
1.03
4.4
3.8
43.51
46.69
ng/l
0.05
34
250
53
438
1.41
0.96
3.0
2.6
—
—
—
0
0
6
27
2.29
0.95
1.8
2.4
118.83
123.53
g/l
—
6
19
6
27
2.29
0.95
1.3
2.5
—
—
—
0
0
35
270
1.43
0.93
11.7
3.4
1754.67
1301.03
ng/l
0.37
30
224
36
285
1.39
0.82
3.0
2.2
58.31
56.15
u/l
0.12
36
261
0
27
0.00
0.78
0.0
1.3
—
—
—
0
0
9
56
1.66
0.74
3.1
8.8
25.64
25.38
mmol/l
—
9
56
88
812
1.42
0.71
28.3
17.8
14.83
14.83
%
0.00
88
800
14
94
1.56
0.71
2.8
4.0
—
—
—
0
0
12
78
1.60
0.69
2.1
3.1
0.21
0.21
g/l
0.18
12
71
0
20
0.00
0.61
0.0
2.0
—
—
—
0
0
19
145
1.38
0.53
1.4
1.3
2.04
11.11
u/ml
—
9
63
7
48
1.49
0.48
9.3
5.0
1.57
1.19
%
—
7
48
27
222
1.29
0.47
1.5
1.3
3.47
1.28
u/ml
—
6
60
104
1008
1.58
0.44
35.5
21.2
39.33
39.72
%
0.30
99
953
104
1008
1.58
0.44
35.9
21.3
130.85
133.37
g/l
1.08
104
989
104
1008
1.58
0.44
35.4
21.1
4.41
4.45
e12/l
0.29
104
979
8
55
1.49
0.44
2.1
1.7
—
—
—
0
0
104
1005
1.64
0.44
35.5
21.2
252.05
252.58
e9/l
0.03
104
979
19
150
1.32
0.44
2.5
3.3
1.60
2.44
e6/l
0.35
14
77
96
919
1.35
0.42
27.0
14.3
22.42
23.60
mg/l
0.13
89
717
15
115
1.35
0.41
22.9
4.4
271.47
246.86
u/l
0.29
15
109
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
73
685
1.20
0.34
6.3
4.4
17.74
12.05
mm/h
1.89
73
621
13
101
1.33
0.33
18.9
8.0
—
—
—
0
0
24
208
1.20
0.27
13.7
1.9
0.71
1.61
mg/l
1.16
17
153
5
38
1.33
0.23
1.0
3.3
8.00
104.45
u/ml
—
5
31
16
188
0.83
0.23
4.8
4.7
2.63
1.73
ug/l
0.73
16
163
18
155
1.19
0.21
1.2
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
2.3
—
—
—
0
0
6
47
1.29
0.21
2.3
1.6
—
—
—
0
0
6
52
1.16
0.19
2.0
1.4
—
—
—
0
0
61
580
1.12
0.18
3.6
3.2
—
—
—
0
0
5
47
1.07
0.09
7.2
6.9
25.60
24.90
mmol/l
—
5
47
23
214
1.09
0.09
3.2
2.2
—
—
—
0
0
6
54
1.12
0.09
1.2
1.4
—
—
—
0
0
10
110
0.90
0.05
3.3
2.4
—
—
—
0
0
17
178
0.95
0.02
1.3
1.5
—
—
—
0
0
10
95
1.06
0.00
3.3
2.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
2.8
—
6.72
—
0
5
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
17.63
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
5
54
0.92
-0.00
2.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
4.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: E4_IDIOPATHIC_HYPOPARATHYROIDISM – Idiopathic hypoparathyroidism
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).